NEW ORLEANS — In a pivotal transition for the landscape of aesthetic and reconstructive medicine, Dr. Babak J. Mehrara, a preeminent authority in oncologic reconstruction, has officially assumed the presidency of The Plastic Surgery Foundation (The PSF). The announcement was made on October 12, 2025, during the opening ceremonies of "Plastic Surgery The Meeting," the American Society of Plastic Surgeons’ (ASPS) flagship annual scientific conference, held this year in the historic medical hub of New Orleans.
Dr. Mehrara, who serves as the Chief of the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center (MSK), brings a wealth of clinical, academic, and research-based leadership to the organization. His tenure, which spans from October 2025 through October 18, 2026, is expected to prioritize the acceleration of high-impact scientific inquiry and the cultivation of the next generation of surgical innovators.
The Core Mandate: Leading The PSF into the Future
The Plastic Surgery Foundation serves as the philanthropic and intellectual engine of the American Society of Plastic Surgeons. It is responsible for funding groundbreaking research, facilitating international humanitarian missions, and ensuring that plastic surgery remains at the cutting edge of evidence-based medicine.
As president, Dr. Mehrara is tasked with overseeing the Foundation’s strategic direction. His leadership comes at a time when the field of plastic surgery is undergoing a profound evolution, moving from purely aesthetic focus to highly specialized, technology-driven reconstructive techniques.
"It is a profound honor to lead The PSF, and I look forward to building on its legacy of excellence in plastic surgery research and innovation," Dr. Mehrara stated in his inaugural address. "I am deeply committed to the advancement of scientific discovery and supporting the work of residents, early-career researchers, and emerging innovators. Throughout my presidency, I will champion new ways to strengthen and expand the Foundation’s mission of research and education."
A Career Defined by Excellence: Chronology and Professional Background
To understand the trajectory of Dr. Mehrara’s presidency, one must examine the career that preceded it. His professional journey has been defined by a relentless pursuit of solutions for complex oncologic reconstruction challenges.
Early Career and Academic Foundation
Dr. Mehrara’s academic pedigree is rooted in the rigorous training environments of top-tier medical institutions. His expertise in surgical oncology reconstruction has made him a sought-after speaker and advisor globally. His joint academic appointment as a Professor of Surgery at Weill Cornell Medical College has allowed him to bridge the gap between bench-side laboratory research and bedside clinical practice, a hallmark of his career.
The MSK Era
Currently, Dr. Mehrara holds the Peter G. Cordeiro Endowed Chair in the Department of Surgery at Memorial Sloan Kettering Cancer Center. His work at MSK is multifaceted. As the director of the National Institutes of Health (NIH)-funded Lymphatic Biology Laboratory, he has led research that has shifted the clinical understanding of lymphatic diseases.
Key Professional Milestones:
- Leadership at MSK: He serves as the Chief of the Plastic and Reconstructive Surgery Service, managing one of the most high-volume and high-complexity departments in the United States.
- Scientific Output: With over 400 peer-reviewed publications, Dr. Mehrara is one of the most cited voices in reconstructive surgery, particularly regarding the surgical and nonsurgical management of cancer-related lymphedema.
- The NIH Connection: His leadership in securing NIH funding for lymphatic research underscores his ability to navigate the complex landscape of grant-based scientific inquiry, a skill that will be vital to his work at The PSF.
Supporting Data: Why Research Matters in Modern Plastic Surgery
The appointment of Dr. Mehrara is a strategic signal from The PSF that the organization intends to double down on scientific rigor. The landscape of modern medicine requires that surgical procedures be backed by significant, reproducible data.
The Lymphedema Challenge
Cancer-related lymphedema is a debilitating condition that affects millions of survivors worldwide. Dr. Mehrara’s expertise in this area is not merely clinical; it is transformative. By integrating his laboratory’s findings into the broader plastic surgery community, he aims to elevate the standard of care for post-surgical complications.
Educational Investment
The PSF invests millions annually in grants and fellowships. Under Dr. Mehrara’s leadership, there is an expected increase in:
- Early-Career Mentorship: Programs designed to retain talented surgical residents in the research pipeline.
- Technological Integration: Utilizing AI and machine learning to predict surgical outcomes in reconstruction.
- Global Access: Expanding the reach of the Foundation’s international educational initiatives to ensure that underserved populations have access to safe, effective, and evidence-based plastic surgery.
Official Responses and Stakeholder Sentiment
The reaction from the plastic surgery community has been overwhelmingly positive, with many citing Dr. Mehrara’s unique ability to speak both the language of the scientist and the language of the surgeon.
"Babak represents the rare intersection of deep clinical empathy and high-level intellectual inquiry," said a fellow member of the ASPS board during the New Orleans meeting. "His leadership will ensure that The PSF is not just a funding body, but an incubator for the next breakthroughs in patient care."
Dr. Mehrara’s emphasis on "emerging innovators" is particularly resonant. In an era where many surgical fellowships are increasingly focused on volume, his focus on the why and how of scientific discovery provides a necessary counter-balance, ensuring that the field does not stagnate.
Implications for the Field: Looking Toward 2026
What will a "Mehrara-led" PSF look like? Based on his past performance and his statements at the inaugural event, we can expect several key developments over the next year.
1. Strengthening Global Partnerships
Dr. Mehrara has signaled that he intends to build stronger partnerships with international surgical societies. His goal is to standardize the metrics of success for reconstructive surgeries globally, ensuring that patients, regardless of geography, receive care that meets the same high benchmarks as those at top-tier centers like MSK.
2. High-Impact Research Initiatives
Under his tenure, the Foundation is expected to pivot toward "high-impact" research. This means moving away from small, observational studies and toward large-scale, multi-center trials that provide the level of clinical evidence required by insurance providers and healthcare systems to validate new reconstructive technologies.
3. Democratization of Knowledge
Through his extensive history of teaching, Dr. Mehrara has shown a commitment to the "democratization of surgical excellence." Expect to see an expansion of The PSF’s digital education platforms, allowing surgeons in private practice and academic settings alike to access the latest techniques in real-time.
4. Patient-Centric Innovation
Perhaps most importantly, Dr. Mehrara’s vision is firmly anchored in the patient experience. His work in lymphedema is inherently patient-centric, focusing on the long-term quality of life of cancer survivors. This focus will likely permeate the Foundation’s grant-making process, favoring projects that improve functional outcomes and patient satisfaction scores.
Conclusion
As the curtains closed on "Plastic Surgery The Meeting" in New Orleans, the path ahead for The Plastic Surgery Foundation appeared clearer than ever. Dr. Babak J. Mehrara’s appointment is not just a change in leadership; it is a declaration of intent. By placing a world-class researcher and clinical innovator at the helm, the Foundation has signaled that the future of plastic surgery will be defined by rigorous science, improved patient access, and a commitment to the next generation of medical pioneers.
From now until October 2026, the surgical world will be watching closely as Dr. Mehrara works to fulfill his ambitious agenda. With his track record of academic excellence, peer-reviewed authority, and a deep-seated commitment to the betterment of patient lives, the outlook for The PSF—and for the patients who benefit from its work—remains remarkably bright. The integration of his expertise into the Foundation’s strategic planning will undoubtedly leave a lasting imprint on the profession for years to come.
About the Author
